Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "RNA Analysis Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.
The global RNA analysis market size was estimated at USD 8.62 billion in 2024 and is projected to reach USD 23.65 billion by 2033, growing at a CAGR of 12.55% from 2025 to 2033.
This growth is driven by the rising demand for transcriptomic studies in precision medicine, advancements in next-generation sequencing (NGS) technologies, and increasing applications of RNA biomarkers in disease diagnostics and drug discovery.
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the global RNA analysis market on the basis of product, technology, application, end use, and region.
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Report Deliverables
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Advances in sequencing technologies
3.2.1.2. Drug development and vaccine research
3.2.2. Market Restraint Analysis
3.2.2.1. Higher Cost of Research & Developments
3.2.2.2. High Costs Associated With Analysis Platforms
3.3. Industry Analysis Tools
3.3.1. Porter's Five Forces Analysis
3.3.2. PESTEL Analysis
Chapter 4. Product Business Analysis
4.1. Product Segment Dashboard
4.2. Global RNA Analysis Market: Product Movement Analysis
4.3. Global RNS Analysis Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Instruments
4.4.1. Instruments Market, 2021-2033 (USD Million)
4.5. Kits & Reagents
4.5.1. Kits & Reagents Market, 2021-2033 (USD Million)
4.5.2. miRNA & siRNA
4.5.2.1. miRNA & siRNA Market, 2021-2033 (USD Million)
4.5.3. Reverse Transcriptases & RT-PCR
4.5.3.1. Reverse Transcriptases & RT-PCR Market, 2021-2033 (USD Million)
4.5.4. RNA Extraction & Purification
4.5.4.1. RNA Extraction & Purification Market, 2021-2033 (USD Million)
4.5.5. RNA Interference
4.5.5.1. RNA Interference Market, 2021-2033 (USD Million)
4.5.6. Others
4.5.6.1. Other Kits & Reagents Market, 2021-2033 (USD Million)
4.6. Services
4.6.1. Services Market, 2021-2033 (USD Million)
Chapter 5. Technology Business Analysis
5.1. Technology Segment Dashboard
5.2. Global RNA Analysis Market: Technology Movement Analysis
5.3. Global RNS Analysis Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Real Time-PCR (qPCR)
5.4.1. Real Time-PCR (qPCR) Market, 2021-2033 (USD Million)
5.5. Microarray
5.5.1. Microarray Market, 2021-2033 (USD Million)
5.6. Sequencing
5.6.1. Sequencing Market, 2021-2033 (USD Million)
5.7. Others
5.7.1. Other Technologies Market, 2021-2033 (USD Million)
Chapter 6. Application Business Analysis
6.1. Application Segment Dashboard
6.2. Global RNA Analysis Market: Application Movement Analysis
6.3. Global RNS Analysis Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Construction of RNA Expression Atlas
6.4.1. Construction of RNA Expression Atlas Market, 2021-2033 (USD Million)
6.5. Epigenetics
6.5.1. Epigenetics Market, 2021-2033 (USD Million)
6.6. Infectious Diseases & Pathogenesis
6.6.1. Infectious Diseases & Pathogenesis Market, 2021-2033 (USD Million)
6.7. Alternative RNA Splicing
6.7.1. Alternative RNA Splicing Market, 2021-2033 (USD Million)
6.8. RNA Structure & Molecular Dynamics
6.8.1. RNA Structure & Molecular Dynamics Market, 2021-2033 (USD Million)
6.9. Development & Delivery of RNA Therapeutics
6.9.1. Development & Delivery of RNA Therapeutics Market, 2021-2033 (USD Million)
6.10. Others
6.10.1. Other Applications Market, 2021-2033 (USD Million)
Chapter 7. End Use Business Analysis
7.1. End Use Segment Dashboard
7.2. Global RNA Analysis Market: End Use Movement Analysis
7.3. Global RNS Analysis Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Government Institutes & Academic Centers
7.4.1. Government Institutes & Academic Centers Market, 2021-2033 (USD Million)
7.5. Pharmaceutical & Biotechnology Companies
7.5.1. Pharmaceutical & Biotechnology Companies Market, 2021-2033 (USD Million)
7.6. Hospitals & Clinics
7.6.1. Hospitals & Clinics Market, 2021-2033 (USD Million)
7.7. Contract Research Organizations (CROs)
7.7.1. Contract Research Organizations (CROs) Market, 2021-2033 (USD Million)
Companies Featured
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Pacific Bioscience of California, Inc.
- Affymetrix, Inc.
- Danaher
- Promega
For more information about this report visit https://www.researchandmarkets.com/r/r166d8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
